Brind.

Illumina and Harmony Biosciences Holdings, Inc. were classified as stocks in the Medical-Biomedical and Genetics sector on July 15, 2025.

1 report, 1 independent Updated Jul 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Illumina and Harmony Biosciences Holdings, Inc. were classified as stocks in the Medical-Biomedical and Genetics sector on July 15, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

  • Illumina

    American company that develops systems for the analysis of genetic variation

    Nothing else this week.

Related events

Coverage

Newest first; wire copies grouped
  • ZacksHRMY vs. ILMN: Which Stock Should Value Investors Buy Now? Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Harmony Biosciences Holdings